Meredith Sewell

Meredith Sewell has extensive work experience in regulatory operations and global regulatory affairs. Meredith currently holds the position of VP, Regulatory Operations at Sarepta Therapeutics since October 2022, where they are responsible for leading the deployment and advancement of the company's RIMS/DMS platform and processes. Prior to this, they worked as the Executive Director of Global Regulatory Operations at Sarepta Therapeutics from November 2020 to October 2022, where they were involved in building the regulatory operations function and establishing long-term strategies for major global dossier filings.

Before joining Sarepta Therapeutics, Meredith was the President of Novalink Consulting LLC from July 2020 to November 2020. Prior to that, they worked at Allergan in various roles, including Executive Director of Global Regulatory Submissions from March 2017 to November 2020, Director of Global Regulatory Publishing from February 2011 to March 2017, and Associate Director of Global Regulatory Affairs Publishing from March 2006 to April 2011.

Meredith'searlier experience includes working at Amgen, where they held positions such as Manager of Regulatory Affairs from September 2004 to February 2006, Associate Manager of Regulatory Affairs Publishing from September 2003 to August 2004, Supervisor of Regulatory Affairs Publishing from August 2001 to September 2003, Associate II from July 2000 to August 2001, and Associate I from June 1998 to July 2000.

Meredith Sewell's education history includes a Bachelor of Arts degree in English from UC Irvine.